Lilly (Eli) (LLY)

NYSE Health Care Pharmaceuticals S&P 500

$1,354.00

-10.73 (-0.79%)

Close of Nov 06, 2026 · end-of-day data

Source: Lilly (Eli)'s 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$18.31B	$19.97B	$21.49B	$22.32B	$24.54B	$28.32B	$28.54B	$34.12B	$45.04B	$65.18B
Cost of revenue	$4.16B	$4.45B	$4.68B	$4.72B	$5.48B	$7.31B	$6.63B	$7.08B	$8.42B	$11.05B
Gross profit	$14.15B	$15.53B	$16.81B	$17.60B	$19.06B	$21.01B	$21.91B	$27.04B	$36.62B	$54.13B
Research & development	$5.04B	$5.10B	$5.05B	$5.59B	$5.98B	$6.93B	$7.19B	$9.31B	$10.99B	$13.34B
Selling, general & admin	$5.84B	$5.98B	$5.98B	$6.21B	$6.12B	$6.43B	$6.44B	$7.40B	$8.59B	$11.09B
Interest expense	$185.20M	$225.00M	$242.50M	$400.60M	$359.60M	$339.80M	$331.60M	$485.90M	$781.00M	$895.00M
Pre-tax income	$3.28B	$2.30B	$3.68B	$5.27B	$7.23B	$6.16B	$6.81B	$6.55B	$12.68B	$25.73B
Income tax	$551.40M	$2.39B	$529.50M	$628.00M	$1.04B	$573.80M	$561.60M	$1.31B	$2.09B	$5.09B
Net income	$2.74B	-$204.10M	$3.23B	$8.32B	$6.19B	$5.58B	$6.24B	$5.24B	$10.59B	$20.64B
EPS (basic)	$2.59	$-0.19	$3.14	$8.93	$6.82	$6.15	$6.93	$5.82	$11.76	$23.00
EPS (diluted)	$2.58	$-0.19	$3.13	$8.89	$6.79	$6.12	$6.90	$5.80	$11.71	$22.95
Diluted shares	1.06B	1.05B	1.03B	935.68M	912.50M	911.68M	904.62M	903.30M	904.10M	899.30M
Gross margin	77.3%	77.7%	78.2%	78.8%	77.7%	74.2%	76.8%	79.2%	81.3%	83.0%
Net margin	14.9%	-1.0%	15.0%	37.3%	25.2%	19.7%	21.9%	15.4%	23.5%	31.7%

Balance sheet

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$4.58B	$6.21B	$7.32B	$2.34B	$3.66B	$3.82B	$2.07B	$2.82B	$3.27B	$7.27B
Short-term investments	$1.46B	$1.50B	$88.20M	$101.00M	$24.20M	$90.10M	$144.80M	$109.10M	$154.80M	—
Receivables	$4.03B	$3.98B	$4.59B	$4.55B	$5.88B	$6.67B	$6.90B	$9.09B	$11.01B	$17.76B
Inventory	$3.56B	$3.40B	$3.10B	$3.19B	$3.98B	$3.89B	$4.31B	$5.77B	$7.59B	$13.74B
Total current assets	$15.10B	$19.20B	$20.55B	$13.71B	$17.46B	$18.45B	$18.03B	$25.73B	$32.74B	$55.63B
Goodwill	$3.97B	$1.38B	$1.37B	$3.68B	$3.77B	$3.89B	$4.07B	$4.94B	$5.77B	$5.90B
Total assets	$38.81B	$44.98B	$43.91B	$39.29B	$46.63B	$48.81B	$49.49B	$64.01B	$78.72B	$112.48B
Total current liabilities	$10.99B	$14.54B	$11.89B	$11.78B	$12.48B	$15.05B	$17.14B	$27.29B	$28.38B	$35.23B
Short-term debt	$1.94B	$3.71B	$1.10B	$1.50B	$8.70M	$1.54B	$1.50B	$6.90B	$5.12B	$1.64B
Long-term debt	$8.37B	$9.94B	$9.20B	$13.82B	$16.59B	$15.35B	$14.74B	$18.32B	$28.53B	$40.87B
Total debt	$10.31B	$13.65B	$10.30B	$15.32B	$16.60B	$16.88B	$16.24B	$25.23B	$33.64B	$42.50B
Total liabilities	$24.80B	$33.39B	$34.08B	$36.68B	$40.99B	$39.83B	$38.84B	$53.23B	$64.44B	$85.94B
Shareholders' equity	$14.01B	$11.59B	$9.83B	$2.61B	$5.64B	$8.98B	$10.65B	$10.77B	$14.27B	$26.54B

Cash flow

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	$4.85B	$5.62B	$5.52B	$4.84B	$6.50B	$7.37B	$7.59B	$4.24B	$8.82B	$16.81B
Free cash flow	$4.85B	$5.62B	$5.52B	$4.84B	$6.50B	$7.37B	$7.59B	$4.24B	$8.82B	$16.81B
Investing cash flow	-$3.14B	-$3.78B	$1.91B	-$8.08B	-$2.26B	-$2.87B	-$3.76B	-$7.15B	-$9.30B	-$10.97B
Financing cash flow	-$559.80M	$142.60M	-$5.90B	-$2.32B	-$3.14B	-$4.13B	-$5.41B	$3.50B	$1.23B	-$2.21B
Dividends paid	$2.16B	$2.19B	$2.31B	$2.41B	$2.69B	$3.09B	$3.54B	$4.07B	$4.68B	$5.38B
Share buybacks	$600.10M	$299.80M	$4.15B	$4.40B	$500.00M	$1.25B	$1.50B	$750.00M	$2.50B	$4.11B
Stock-based compensation	$255.30M	$281.30M	$279.50M	$312.40M	$308.10M	$342.80M	$371.10M	$629.00M	$646.00M	$626.00M
Depreciation & amortization	$1.50B	$1.57B	$1.61B	$1.23B	$1.32B	$1.55B	$1.52B	$1.53B	$1.77B	$2.00B

Income statement

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	$9.35B	$8.77B	$11.30B	$11.44B	$13.53B	$12.73B	$15.56B	$17.60B	$19.29B	$19.80B	$22.97B	$24.40B
Cost of revenue	$1.79B	$1.67B	$2.17B	$2.17B	$2.40B	$2.23B	$2.45B	$3.01B	$3.37B	$3.58B	$3.27B	$3.93B
Gross profit	$7.57B	$7.09B	$9.13B	$9.27B	$11.13B	$10.50B	$13.11B	$14.59B	$15.92B	$16.22B	$19.71B	$20.46B
Research & development	$2.56B	$2.52B	$2.71B	$2.73B	$3.02B	$2.73B	$3.34B	$3.47B	$3.80B	$3.51B	$3.82B	$4.25B
Selling, general & admin	$1.93B	$1.95B	$2.12B	$2.10B	$2.42B	$2.47B	$2.75B	$2.74B	$3.13B	$2.93B	$3.43B	$3.12B
Interest expense	$138.20M	$179.60M	$183.60M	$192.70M	$225.10M	$243.70M	$249.00M	$179.60M	$222.60M	—	—	—
Pre-tax income	$2.51B	$2.54B	$3.52B	$1.59B	$5.04B	$3.46B	$6.78B	$7.23B	$8.27B	$8.85B	$9.25B	$8.41B
Income tax	$318.90M	$293.20M	$550.20M	$618.10M	$628.50M	$697.00M	$1.12B	$1.65B	$1.63B	$1.45B	$2.15B	$1.96B
Net income	$2.19B	$2.24B	$2.97B	$970.30M	$4.41B	$2.76B	$5.66B	$5.58B	$6.64B	$7.40B	$7.09B	$6.45B
EPS (basic)	$2.43	$2.49	$3.29	$1.08	$4.90	$3.07	$6.30	$6.22	$7.40	$8.27	$7.95	$7.23
EPS (diluted)	$2.42	$2.48	$3.28	$1.07	$4.88	$3.06	$6.29	$6.21	$7.39	$8.26	$7.94	$7.22
Diluted shares	200.00K	903.80M	904.20M	905.00M	-300.00K	900.60M	899.80M	898.80M	-400.00K	895.90M	893.70M	893.40M
Gross margin	80.9%	80.9%	80.8%	81.0%	82.2%	82.5%	84.3%	82.9%	82.5%	81.9%	85.8%	83.9%
Net margin	23.4%	25.6%	26.3%	8.5%	32.6%	21.7%	36.4%	31.7%	34.4%	37.4%	30.9%	26.4%

Balance sheet

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Cash & equivalents	$2.82B	$2.46B	$3.22B	$3.37B	$3.27B	$3.09B	$3.38B	$9.79B	$7.27B	$5.28B	$8.95B	$4.88B
Short-term investments	$109.10M	$126.10M	$140.40M	$149.40M	$154.80M	$127.40M	$170.10M	$121.60M	—	—	—	—
Receivables	$9.09B	$7.89B	$11.03B	$10.29B	$11.01B	$12.04B	$14.17B	$16.11B	$17.76B	$18.43B	$20.08B	$22.09B
Inventory	$5.77B	$6.10B	$6.48B	$7.46B	$7.59B	$9.31B	$11.01B	$12.18B	$13.74B	$14.53B	$16.79B	$18.19B
Total current assets	$25.73B	$25.19B	$30.20B	$31.42B	$32.74B	$41.26B	$49.85B	$62.07B	$55.63B	$54.84B	$64.67B	$65.26B
Goodwill	$4.94B	$4.94B	$5.77B	$5.77B	$5.77B	$5.77B	$5.77B	$5.90B	$5.90B	$6.13B	$8.85B	$9.87B
Total assets	$64.01B	$63.94B	$71.87B	$75.61B	$78.72B	$89.39B	$100.92B	$114.94B	$112.48B	$116.58B	$142.28B	$148.07B
Total current liabilities	$27.29B	$18.60B	$27.12B	$24.67B	$28.38B	$30.07B	$39.02B	$40.14B	$35.23B	$36.63B	$47.74B	$47.00B
Short-term debt	$6.90B	$1.65B	$5.16B	$2.07B	$5.12B	$4.02B	$5.72B	$1.63B	$1.64B	$4.00B	$7.05B	$2.52B
Long-term debt	$18.32B	$24.56B	$23.73B	$29.05B	$28.53B	$34.50B	$34.18B	$40.87B	$40.87B	$39.37B	$47.86B	$46.99B
Total debt	$25.23B	$26.21B	$28.89B	$31.12B	$33.64B	$38.52B	$39.90B	$42.51B	$42.50B	$43.37B	$54.91B	$49.50B
Total liabilities	$53.23B	$51.13B	$58.31B	$61.37B	$64.44B	$73.62B	$82.65B	$91.14B	$85.94B	$85.38B	$108.40B	$107.80B
Shareholders' equity	$10.77B	$12.81B	$13.56B	$14.24B	$14.27B	$15.76B	$18.27B	$23.79B	$26.54B	$31.20B	$33.88B	$40.27B

Cash flow

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Operating cash flow	-$312.00M	$1.17B	$1.47B	$3.71B	$2.47B	$1.67B	$3.09B	$8.84B	$3.23B	$5.33B	$10.69B	$11.40B
Free cash flow	-$312.00M	$1.17B	$1.47B	$3.71B	$2.47B	$1.67B	$3.09B	$8.84B	$3.23B	$5.33B	$10.69B	$11.40B
Investing cash flow	-$2.92B	-$1.18B	-$2.20B	-$4.00B	-$1.92B	-$3.35B	-$1.83B	-$2.98B	-$2.80B	-$3.92B	-$15.40B	-$8.30B
Financing cash flow	$3.55B	-$311.30M	$1.56B	$211.30M	-$225.50M	$1.38B	-$1.25B	$531.00M	-$2.88B	-$3.47B	$8.43B	-$7.22B
Dividends paid	$1.02B	$1.17B	$1.17B	$1.17B	$1.17B	$1.35B	$1.35B	$1.35B	$1.34B	$1.55B	$1.55B	$1.54B
Share buybacks	$0	$0	$0	$446.10M	$2.05B	$1.20B	$692.00M	$708.00M	$1.51B	$2.36B	$1.60B	$377.00M
Stock-based compensation	$120.70M	$159.40M	$211.10M	$133.20M	$142.30M	$154.00M	$185.00M	$151.00M	$136.00M	$161.00M	$201.00M	$200.00M
Depreciation & amortization	$387.40M	$400.60M	$414.40M	$466.80M	$485.20M	$463.00M	$478.00M	$470.00M	$586.00M	$509.00M	$534.00M	$545.00M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.